We identified a significant downregulation in the expression of a long non-coding RNA, Down syndrome cell adhesion molecule antisense DSCAM-AS1, in response to progesterone treatment in breast cancer. This evidence concerns the gene DSCAM-AS1 and breast carcinoma.